Rozhovory s odborníky na 3PM
Apotheken Umschau, 15 November 2021, Looking into the crystal ball, Nina Himmer
Professor Dr. Olga Golubnitschaja was interviewed
The specialist in bio-medicine, Prof. Golubnitschaja heads the research group for 3P (predictive, preventive and personalised) medicine at the University Hospital in Bonn, is president of the European Predictive, Preventive and Personalised Medicine Association (EPMA) and is considered a pioneer of this "3P" medicine in Germany and throughout Europe. "It is an issue that we can predict diseases for which there are no therapies yet. There is a great need for better patient counselling," she says.
For Prof. Golubnitschaja, the three Ps - prediction, prevention and personalised medicine - cannot be considered separately from each other. "The goal must be to predict diseases or assess their risk and at the same time offer individual solutions for improved patient outcomes," she says.
Short Curriculum vitae
Olga Golubnitschaja, Dr. Professor
Prof. Dr. Golubnitschaja is the head of the world first Predictive, Preventive Personalised (3P) Medicine unit at the Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany. OG is educated in journalism, biotechnology and medicine and has been awarded research fellowships in Austria, Russia, UK, Germany, Netherlands, and Switzerland (early and predictive diagnostics in paediatrics, neurosciences and cancer).